Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market, Global Outlook and Forecast 2023-2028

Report ID: 1372095 | Published Date: Jan 2025 | No. of Page: 76 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Overall Market Size
    2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size: 2021 VS 2028
    2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales: 2017-2028
3 Company Landscape
    3.1 Top Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players in Global Market
    3.2 Top Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Companies Ranked by Revenue
    3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Companies
    3.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Companies
    3.5 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players in Global Market
        3.8.1 List of Global Tier 1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Companies
        3.8.2 List of Global Tier 2 and Tier 3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Markets, 2021 & 2028
        4.1.2 Dominant Optic Atrophy
        4.1.3 Recessive Optic Atrophy
    4.2 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue & Forecasts
        4.2.1 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2017-2022
        4.2.2 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2023-2028
        4.2.3 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    4.3 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales & Forecasts
        4.3.1 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2017-2022
        4.3.2 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2023-2028
        4.3.3 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    4.4 By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Eye Clinics
        5.1.4 Medical Research Institute
        5.1.5 Other
    5.2 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue & Forecasts
        5.2.1 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2017-2022
        5.2.2 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2023-2028
        5.2.3 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    5.3 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales & Forecasts
        5.3.1 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2017-2022
        5.3.2 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2023-2028
        5.3.3 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    5.4 By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2021 & 2028
    6.2 By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue & Forecasts
        6.2.1 By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2017-2022
        6.2.2 By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2023-2028
        6.2.3 By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    6.3 By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales & Forecasts
        6.3.1 By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2017-2022
        6.3.2 By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2023-2028
        6.3.3 By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2017-2028
        6.4.2 By Country - North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2017-2028
        6.4.3 US Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.4.4 Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.4.5 Mexico Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2017-2028
        6.5.2 By Country - Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2017-2028
        6.5.3 Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.5.4 France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.5.5 U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.5.6 Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.5.7 Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.5.8 Nordic Countries Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.5.9 Benelux Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2017-2028
        6.6.2 By Region - Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2017-2028
        6.6.3 China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.6.4 Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.6.5 South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.6.6 Southeast Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.6.7 India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2017-2028
        6.7.2 By Country - South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2017-2028
        6.7.3 Brazil Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.7.4 Argentina Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, 2017-2028
        6.8.3 Turkey Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.8.4 Israel Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.8.5 Saudi Arabia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
        6.8.6 UAE Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Alkeus Pharmaceuticals
        7.1.1 Alkeus Pharmaceuticals Corporate Summary
        7.1.2 Alkeus Pharmaceuticals Business Overview
        7.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.1.5 Alkeus Pharmaceuticals Key News
    7.2 Amgen
        7.2.1 Amgen Corporate Summary
        7.2.2 Amgen Business Overview
        7.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.2.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.2.5 Amgen Key News
    7.3 Biovista
        7.3.1 Biovista Corporate Summary
        7.3.2 Biovista Business Overview
        7.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.3.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.3.5 Biovista Key News
    7.4 Editas Medicine
        7.4.1 Editas Medicine Corporate Summary
        7.4.2 Editas Medicine Business Overview
        7.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.4.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.4.5 Editas Medicine Key News
    7.5 GenSight Biologics
        7.5.1 GenSight Biologics Corporate Summary
        7.5.2 GenSight Biologics Business Overview
        7.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.5.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.5.5 GenSight Biologics Key News
    7.6 Ixchel Pharma
        7.6.1 Ixchel Pharma Corporate Summary
        7.6.2 Ixchel Pharma Business Overview
        7.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.6.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.6.5 Ixchel Pharma Key News
    7.7 Khondrion
        7.7.1 Khondrion Corporate Summary
        7.7.2 Khondrion Business Overview
        7.7.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.7.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.7.5 Khondrion Key News
    7.8 Mitotech
        7.8.1 Mitotech Corporate Summary
        7.8.2 Mitotech Business Overview
        7.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.8.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.8.5 Mitotech Key News
    7.9 ProQR Therapeutics
        7.9.1 ProQR Therapeutics Corporate Summary
        7.9.2 ProQR Therapeutics Business Overview
        7.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.9.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.9.5 ProQR Therapeutics Key News
    7.10 Sanofi
        7.10.1 Sanofi Corporate Summary
        7.10.2 Sanofi Business Overview
        7.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.10.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.10.5 Sanofi Key News
    7.11 Spark Therapeutics
        7.11.1 Spark Therapeutics Corporate Summary
        7.11.2 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Business Overview
        7.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.11.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.11.5 Spark Therapeutics Key News
    7.12 Stealth BioTherapeutics
        7.12.1 Stealth BioTherapeutics Corporate Summary
        7.12.2 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Business Overview
        7.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.12.4 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.12.5 Stealth BioTherapeutics Key News
    7.13 Usher Syndrome
        7.13.1 Usher Syndrome Corporate Summary
        7.13.2 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Business Overview
        7.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Major Product Offerings
        7.13.4 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Revenue in Global (2017-2022)
        7.13.5 Usher Syndrome Key News
8 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Capacity, Analysis
    8.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Capacity, 2017-2028
    8.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Capacity of Key Manufacturers in Global Market
    8.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Supply Chain Analysis
    10.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Value Chain
    10.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Upstream Market
    10.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

List of Tables
    Table 1. Key Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in Global Market
    Table 2. Top Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Companies, 2017-2022
    Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Companies, (K Pcs), 2017-2022
    Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (2017-2022) & (USD/Piece)
    Table 8. Global Manufacturers Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Type
    Table 9. List of Global Tier 1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), 2017-2022
    Table 15. By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), 2023-2028
    Table 16. By Application – Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), 2017-2022
    Table 20. By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), 2023-2028
    Table 21. By Region – Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), 2017-2022
    Table 25. By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), 2023-2028
    Table 26. By Country - North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2017-2022
    Table 29. By Country - North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2023-2028
    Table 30. By Country - Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2017-2022
    Table 33. By Country - Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2023-2028
    Table 34. By Region - Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2017-2022
    Table 37. By Region - Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2023-2028
    Table 38. By Country - South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2017-2022
    Table 41. By Country - South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2023-2028
    Table 42. By Country - Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2017-2022
    Table 45. By Country - Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, (K Pcs), 2023-2028
    Table 46. Alkeus Pharmaceuticals Corporate Summary
    Table 47. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 48. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 49. Amgen Corporate Summary
    Table 50. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 51. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 52. Biovista Corporate Summary
    Table 53. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 54. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 55. Editas Medicine Corporate Summary
    Table 56. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 57. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 58. GenSight Biologics Corporate Summary
    Table 59. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 60. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 61. Ixchel Pharma Corporate Summary
    Table 62. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 63. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 64. Khondrion Corporate Summary
    Table 65. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 66. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 67. Mitotech Corporate Summary
    Table 68. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 69. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 70. ProQR Therapeutics Corporate Summary
    Table 71. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 72. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 73. Sanofi Corporate Summary
    Table 74. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 75. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 76. Spark Therapeutics Corporate Summary
    Table 77. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 78. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 79. Stealth BioTherapeutics Corporate Summary
    Table 80. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 81. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 82. Usher Syndrome Corporate Summary
    Table 83. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Offerings
    Table 84. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Piece) (2017-2022)
    Table 85. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
    Table 86. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Capacity Market Share of Key Manufacturers, 2020-2022
    Table 87. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production by Region, 2017-2022 (K Pcs)
    Table 88. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production by Region, 2023-2028 (K Pcs)
    Table 89. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Opportunities & Trends in Global Market
    Table 90. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers in Global Market
    Table 91. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints in Global Market
    Table 92. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Raw Materials
    Table 93. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Raw Materials Suppliers in Global Market
    Table 94. Typical Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Downstream
    Table 95. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Downstream Clients in Global Market
    Table 96. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Type
    Figure 2. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Application
    Figure 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, 2017-2028 (US$, Mn)
    Figure 7. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales in Global Market: 2017-2028 (K Pcs)
    Figure 8. The Top 3 and 5 Players Market Share by Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue in 2021
    Figure 9. By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    Figure 10. By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece), 2017-2028
    Figure 12. By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    Figure 13. By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece), 2017-2028
    Figure 15. By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    Figure 16. By Region - Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    Figure 19. US Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    Figure 24. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 25. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    Figure 33. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 37. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    Figure 40. Brazil Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share, 2017-2028
    Figure 44. Turkey Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Capacity (K Pcs), 2017-2028
    Figure 49. The Percentage of Production Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Region, 2021 VS 2028
    Figure 50. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Leber’s Hereditary Optic Neuropathy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Leber’s Hereditary Optic Neuropathy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Leber’s Hereditary Optic Neuropathy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports